BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu G, Chen T, Ding Z, Wang Y, Wei Y, Wei X. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. Cell Prolif 2021;54:e13009. [PMID: 33655556 DOI: 10.1111/cpr.13009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Jing Z, Okubo H, Morishige JI, Xu P, Hasan N, Nagata N, Ando H. Lenvatinib causes reduced expression of carnitine/organic cation transporter 2 and carnitine deficiency in the skeletal muscle of rats. Toxicol Lett 2022:S0378-4274(22)00138-2. [PMID: 35788046 DOI: 10.1016/j.toxlet.2022.06.012] [Reference Citation Analysis]
2 Sudhesh Dev S, Zainal Abidin SA, Farghadani R, Othman I, Naidu R. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer. Front Pharmacol 2021;12:772510. [PMID: 34867402 DOI: 10.3389/fphar.2021.772510] [Reference Citation Analysis]
3 Meng N, Xie H, Hou J, Chen Y, Wu M, Guo Y, Jiang C. Design and semisynthesis of oleanolic acid derivatives as VEGF inhibitors: Inhibition of VEGF-induced proliferation, angiogenesis, and VEGFR2 activation in HUVECs. Chinese Journal of Natural Medicines 2022;20:229-40. [DOI: 10.1016/s1875-5364(22)60159-6] [Reference Citation Analysis]
4 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Reference Citation Analysis]
5 Kwiatkowska I, Hermanowicz JM, Iwinska Z, Kowalczuk K, Iwanowska J, Pawlak D. Zebrafish—An Optimal Model in Experimental Oncology. Molecules 2022;27:4223. [DOI: 10.3390/molecules27134223] [Reference Citation Analysis]
6 Zhang C, Li N, Suo M, Zhang C, Liu J, Liu L, Qi Y, Zheng X, Xie L, Hu Y, Bu P. Sirtuin 3 deficiency aggravates angiotensin II-induced hypertensive cardiac injury by the impairment of lymphangiogenesis. J Cell Mol Med 2021;25:7760-71. [PMID: 34180125 DOI: 10.1111/jcmm.16661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Liu G, Chen T, Ding Z, Wang Y, Wei Y, Wei X. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. Cell Prolif 2021;54:e13009. [PMID: 33655556 DOI: 10.1111/cpr.13009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
8 Song Z, Li Y, Shang C, Shang G, Kou H, Li J, Chen S, Liu H. Sprifermin: Effects on Cartilage Homeostasis and Therapeutic Prospects in Cartilage-Related Diseases. Front Cell Dev Biol 2021;9:786546. [PMID: 34970547 DOI: 10.3389/fcell.2021.786546] [Reference Citation Analysis]
9 Geindreau M, Bruchard M, Vegran F. Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context. Cancers (Basel) 2022;14:2446. [PMID: 35626056 DOI: 10.3390/cancers14102446] [Reference Citation Analysis]
10 Mahmood HA, Tomas Bort E, Walker AJ, Grose RP, Chioni AM. FGF signalling facilitates cervical cancer progression. FEBS J 2021. [PMID: 34951738 DOI: 10.1111/febs.16331] [Reference Citation Analysis]
11 Liu Y, Li Y, Wang Y, Lin C, Zhang D, Chen J, Ouyang L, Wu F, Zhang J, Chen L. Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy. J Hematol Oncol 2022;15:89. [PMID: 35799213 DOI: 10.1186/s13045-022-01310-7] [Reference Citation Analysis]
12 Dabravolski SA, Khotina VA, Omelchenko AV, Kalmykov VA, Orekhov AN. The Role of the VEGF Family in Atherosclerosis Development and Its Potential as Treatment Targets. Int J Mol Sci 2022;23:931. [PMID: 35055117 DOI: 10.3390/ijms23020931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Vyas D, Patel M, Wairkar S. Strategies for active tumor targeting-an update. Eur J Pharmacol 2021;:174512. [PMID: 34555395 DOI: 10.1016/j.ejphar.2021.174512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Li R, Song X, Guo Y, Song P, Duan D, Chen ZS. Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis. Front Oncol 2021;11:772915. [PMID: 34746014 DOI: 10.3389/fonc.2021.772915] [Reference Citation Analysis]
15 Şen Ö, Marino A, Pucci C, Ciofani G. Modulation of anti-angiogenic activity using ultrasound-activated nutlin-loaded piezoelectric nanovectors. Mater Today Bio 2022;13:100196. [PMID: 35005600 DOI: 10.1016/j.mtbio.2021.100196] [Reference Citation Analysis]
16 Lee HW, Seo HK. Fibroblast Growth Factor Inhibitors for Treating Locally Advanced/Metastatic Bladder Urothelial Carcinomas via Dual Targeting of Tumor-Specific Oncogenic Signaling and the Tumor Immune Microenvironment. Int J Mol Sci 2021;22:9526. [PMID: 34502435 DOI: 10.3390/ijms22179526] [Reference Citation Analysis]